The specific genetic anomalies that have been suggested to predict the neoplastic progression to EAC in BE include the loss of heterozygosity (LOH) at the loci within 17 p and 9 p, which contain the tumor suppressor genes TP53 and CKDN2A, respectively. The gene discussed is TP53; the disease is Barrett esophagus.